New hope for ALS? early safety trial launches
Disease control
Recruiting now
This early-stage trial tests a drug called siplizumab in 48 adults recently diagnosed with ALS. The main goal is to check if the drug is safe and how the body processes it. Researchers will also look at how the drug affects immune cells and ALS symptoms over 52 weeks.
Phase: PHASE1 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC